Enlivex Therapeutics (Enlivex Therapeutics) 3-Year Book Growth Rate : 41.40% (As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Enlivex Therapeutics 3-Year Book Growth Rate?

Enlivex Therapeutics's Book Value per Share for the quarter that ended in Sep. 2023 was $2.09.

During the past 12 months, Enlivex Therapeutics's average Book Value per Share Growth Rate was -39.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 41.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was -21.20% per year. During the past 10 years, the average Book Value per Share Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 12 years, the highest 3-Year average Book Value per Share Growth Rate of Enlivex Therapeutics was 470.10% per year. The lowest was -62.80% per year. And the median was -27.90% per year.

Competitive Comparison of Enlivex Therapeutics's 3-Year Book Growth Rate

For the Biotechnology subindustry, Enlivex Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enlivex Therapeutics's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enlivex Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Enlivex Therapeutics's 3-Year Book Growth Rate falls into.

Enlivex Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Enlivex Therapeutics (NAS:ENLV) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Enlivex Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Enlivex Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Enlivex Therapeutics (Enlivex Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enlivex Therapeutics Ltd (NAS:ENLV) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

ENLV:Israel 1BT:Germany

Address

14 Einstein Street, Nes Ziona, ISR, 7403618

Website

https://www.enlivex.com

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.